Cargando…
Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
BACKGROUND: Melanoma has two key features, an over-representation of UV-induced mutations and resistance to DNA damaging chemotherapy agents. Both of these features may result from dysfunction of the nucleotide excision repair pathway, in particular the DNA damage detection branch, global genome rep...
Autores principales: | Budden, Timothy, van der Westhuizen, Andre, Bowden, Nikola A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787239/ https://www.ncbi.nlm.nih.gov/pubmed/29373959 http://dx.doi.org/10.1186/s12885-018-4010-9 |
Ejemplares similares
-
Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma
por: van der Westhuizen, Andre, et al.
Publicado: (2020) -
Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair
por: Budden, Timothy, et al.
Publicado: (2016) -
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
por: Wong-Brown, Michelle W., et al.
Publicado: (2022) -
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge
por: van der Westhuizen, Andre, et al.
Publicado: (2022) -
The Role of Altered Nucleotide Excision Repair and UVB-Induced DNA Damage in Melanomagenesis
por: Budden, Timothy, et al.
Publicado: (2013)